1/26/2010-Johson & Johnson (NYSE:JNJ) reported Q4 EPS of $1.02, topping consensus estimates of $0.97. Sales in the quarter rose 9% year-over-year to $16.6 billion, and...
The diversified health care giant operates in three segments through more than 250 operating companies located in some 60 countries. Its Pharmaceuticals division makes drugs...
Both J&J and Genentech Boost 2008 Profit Outlooks; Johnson & Johnson 2Q US Sales Up 2%, Global Sales Up 16%; Genentech Best Biotech Performer Today,...
7/9/2010-Johnson & Johnson (NYSE:JNJ) recalled more Tylenol and other over-the-counter drugs Thursday after they were tied to musty odor, furthering the recall they launched in...